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Abstract
Background: Bo-Gan-Whan (BGH), a Korean polyherbal medicine, is used as a hepatoprotective drug. It has six
natural sources, and has been demonstrated to have anti-oxidative, anti-cancer, and anti-inflammatory properties;
however, its effect on vascular diseases remains unclear.
Methods: Cell viability and proliferation assays were employed using an EZ-Cytox Cell Viability Assay Kit. Platelet-
derived growth factor (PDGF)-BB-induced vascular smooth muscle cell (VSMC) migration was measured by scratch
wound healing assay and Boyden chamber assay. The expression levels of the phosphorylated signaling proteins
relevant to proliferation, including extracellular signal-regulated kinase (ERK) 1/2 and p38 mitogen-activated protein
kinase (MAPK) were determined by western blot analysis. Chromatogram and mass analysis were employed by Ultra
Performance Liquid Chromatography (UPLC) system. Cell prolife ration and migration were also explored using the
PDGF-BB-induced aortic sprout assay.
Results: BGH (100–500 μg/mL) significantly inhibited the proliferation and migration of PDGF-BB-stimulated VSMCs
through the reduced phosphorylation of ERK1/2 and p38 MAPK in comparison to untreated PDGF-BB-stimulated
VSMC. Moreover, we identified the paeoniflorin as the major composition of BGH.
Conclusions: We suggest that BGH may have an anti-atherosclerosis effect by inhibiting the proliferation and
migration of PDGF-BB-stimulated VSMCs through down-regulation of ERK1/2 and p38 MAPK phosphorylation.
Keywords: Bo-Gan-Whan, Vascular smooth muscle cells, Platelet-derived growth factor-BB, Extracellular signal-
regulated kinase 1/2, p38 mitogen-activated protein kinase
Abbreviations: BGH, Bo-Gan-Whan; BSA, Bovine serum albumin; DMEM, Dulbecco’s Modified Eagle’s Medium;
ERK, Extracellular signal-regulated kinase; FBS, Fetal bovine serum; MAPK, Mitogen-activated protein kinases;
PDGF, Platelet-derived growth factor; UPLC, Ultra Performance Liquid Chromatography; VSMC, Vascular smooth
muscle cell
Background
Vascular disorders are among the major causes of health
problems or death, particularly in western countries [1].
Acute coronary diseases are associated with mortality
and therefore require urgent medical attention such as
stent therapy to restore blood flow to a narrowed blood
vessel [2]. However, the stent therapy has an inevitable
risk factor such as vascular restenosis [3]. Particularly
in vascular lesion, abnormal physiological responses of
smooth muscle cells (VSMCs) underlying cell migration
and proliferation are the major mechanism of developing
vascular restenosis [4]. Therefore, controlling pathological
progressions of VSMCs is one of the major methods
under consideration to prevent the restenosis [5, 6].
Several studies have shown that VSMCs motility and
hyperplasia in response to arterial pathogenesis were stim-
ulated by platelet-derived growth factor (PDGF) [7, 8].
PDGF-BB can stimulate arterial pathogenesis signal cas-
cades such as PDGF beta receptor and its downstream sig-
naling molecules, consequently resulted in an increasing
phosphorylated p38 mitogen-activated protein kinase and
activated of extracellular signal-regulated kinase 1/2 [9, 10].
Recently, functional foods or medical food supple-
ments have been used in health-promotion or disease
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prevention-strategies. This requires the discovery and
development of products from natural sources that may
provide alternative interventions to currently approved
medicine [11, 12]. The majority of patients who undergo
angioplasty through stents, require inevitable medication
for a long period of time to avoid the progression or re-
occurrence of restenosis [13]. For these reasons, Korean
traditional medicines have been used as an alternative to
treat diverse human diseases and to maintain good health
[14]. Thus, in this study, we investigated the efficacy of
Bo-Gan-Whan (BGH) in restenosis. According to the
Korean medical encyclopedia, BGH has been traditionally
prescribed for infirmed liver and for general hepatic-
protection. However, to date, the anti-migration and pro-
liferation of VSMCs after treatment with BGH is not fully
understood. Hence, we attempted to investigate the anti-
restenosis effect of BGH on PDGF-BB-stimulated VSMCs




The EZ-Cytox Cell Viability Assay Kit were purchased
from Daeil Lab Service (Seoul, Korea) and cell culture ma-
terials were purchased from Gibco-BRL (Gaithersburg,
MD, USA), respectively. Recombinant PDGF-BB was ob-
tained from R&D systems (Minneapolis, MN, USA). Spe-
cific antibodies for GAPDH, ERK1/2, phosphorylation of
ERK1/2, p38, and phosphorylation of p38 for analysis of
western blots, were purchased from Santa Cruz Biotech-
nology (Santa Cruz, CA, USA). All other chemicals were
purchased from Sigma (St. Louis, MO, USA).
Plant material and extraction
BGH (5 g Ostericum koreanum rhizome, 5 g Anglicae
gigas root, 5 g Ledebouriella seseloides root, 5 g Paeonia
lactiflora root, 5 g Rehmannia glutinosa root, and 5 g
Cnidium officinale. Makino) was obtained from Dongguk
University Oriental Hospital, Korea which has been pre-
pared specifically for this study from the commercially-
available products. The plants were blended (a total of
30 g), and the crude powder was boiled in 1000 mL of
sterile deionized water at 100 °C for 3 h. The aqueous ex-
tracts were concentrated and evaporated at 60 °C under
vacuum. The extract was then lyophilized by freeze-drying
at −60 °C.
Isolation and cultivation of primary VSMCs from rats
Aortic VSMCs were isolated from male Sprague–Dawley
(SD) rats following previously described protocols [15].
VSMCs were cultured in Dulbecco’s Modified Eagle’s
Medium (DMEM) low glucose supplemented with 10 %
fetal bovine serum (FBS), 100 U/mL penicillin, 100 g/mL
streptomycin, and 200 mM glutamine at 37 °C under a
humidified 95 % air/5 % CO2 mixture (v/v). All protocols
for animal experiments were approved by the ethics
committee of Dongguk University (IACUC-2014-009).
The cell viability assay
VSMCs were seeded at 2 × 104 cells/mL in a 96-well mi-
croplate containing DMEM and incubated for 24 h. The
cells were then incubated with different concentrations
of BGH (10–500 μg/mL) in DMEM for 24 h. The cell
viability of VSMCs was determined by the EZ-Cytox Cell
Viability Assay Kit at 450 nm. The effects of BGH were
then determined based on the relative cell viability of
the treated group in comparison to the untreated group.
The assay of VSMCs’ proliferation
VSMCs (2 × 104 cells/mL) were seeded in a 96-well mi-
croplate containing DMEM and incubated for 24 h.
These cells were incubated in serum-free media for 12 h.
VSMCs were then incubated with different concentra-
tions of BGH (10–500 μg/mL) and PDFG-BB (10 ng/
mL) for an additional 24 h. The proliferation rate of
VSMCs was determined by the EZ-Cytox Cell Viability
Assay Kit at 450 nm.
Scratch wound healing assay
VSMCs (4 × 104 cells/mL) were incubated in a 6-well
dish in growth medium for 24 h and then incubated in
serum-deprivation media for 24 h. To induce a migrat-
ing zone in transverse scratch wound, each monolayer of
VSMCs was scratched with a sterilized 200 μL-tip. Sub-
sequently, VSMCs were treated with PDGF-BB (10 ng/
mL) and BGH (100–500 μg/mL) for an additional 24 h.
VSMC morphological changes were examined and re-
corded using an inverted microscope and CCD camera
(IX71; Olympus, Tokyo, Japan). The migrating zone was
examined and analyzed between 0 h to 24 using Image J
software.
Boyden chamber assay
The PDGF-BB-mediated VSMC migration assay was per-
formed using a Boyden chamber, as previously described
[15]. VSMCs were harvested from the grown-up in
serum-free media for 24 h. A density of 1 × 106 cell/mL of
VSMCs in 50 μL DMEM supplemented 0.1 % bovine
serum albumin (BSA) in the upper chamber, which was
then inserted in the lower chamber containing PDGF-BB
(10 ng/mL) and various concentrations of BGH (100–
500 μg/mL) in 28 μL DMEM supplemented 0.1 % BSA.
The migrated VSMCs on the membrane for 90 min were
analyzed using Image J software.
Western blot analysis
VSMC lysates were separated by electrophoresis using
12 % acrylamide gels and then transferred to polyvinylidene
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difluoride membranes in transfer buffer at 4 °C for 2 h.
The membrane was treated with Tris-buffered saline con-
taining 5 % BSA at room temperature for 1 h and then
incubated overnight at 4 °C with antibodies for phosphor-
ylated ERK1/2 (p-ERK1/2) or p38 (p-p38), total ERK1/2
(T-ERK1/2) or p38 (Tp38), and GAPDH at 1:1000 dilu-
tion. The membranes were washed in Tris-buffered saline
containing 0.1 % Tween 20, and then incubated with a
1:1000 dilution of anti-IgG secondary antibody conjugated
to horseradish peroxidase for 1 h. The expression levels of
each protein were analyzed via chemiluminescence and
quantified using Image J Software.
The assay of aortic sprout ring growth
Ex vivo properties of vessels were measured by an aortic
sprout assay, as previously described [16]. Owing to the
protocol, the endothelium and adventitium of the aorta
from SD rats (5-weeks-old, n = 4) were removed mech-
anically and enzymatically, and the internal vessels were
cut into 1-mm2 strips. The strips were embedded in 48-
well plates coated with matrigel, and then treated with
PDGF-BB (10 ng/mL) and BGH (100–500 μg/mL) in
FBS-free DMEM for five days. The strips were stained
with Diff-Quik (Baxter Healthcare) and photographed,
and the length of sprout was analyzed using Image J
software.
Ultra -performance liquid chromatography (UPLC)-based
analysis
UPLC-based fingerprinting was performed with an UPLC
system (Waters, Corporation, Milford, USA), equipped
with a quaternary pump, a vacuum degasser, diode-array
detector and Waters software. Separation was performed
using a UPLC™ BEH C18 column (1.7 μm, 2.1 mm ×
50 mm). The mobile phase was a mixture of 0.1 % (v/v) of
acetonitrile and water containing 0.1 % (v/v) formic acid
at a flow rate of 0.3 mL/min. A standard solution contain-
ing paeoniflorin (Sigma-Aldrich, MO, USA) was prepared
by dissolving these compounds in distilled water (10 mg/
100 mL). The solution was filtered through a 0.45 μm
membrane filter, after which UPLC was performed.
Statistical analysis
GraphPad Prism (GraphPad, San Diego, USA) was used to
analyze statistical data analysis. The results were presented
as the mean ± standard error (SE) of at least three inde-
pendent experiments (n ≥ 3). The results were assessed
using a Student’s t-test and one-way ANOVA followed by
Tukey's multiple range test. Statistical significance was
considered at P < 0.05.
Results
BGH inhibits the proliferation of PDGF-BB-induced VSMCs
To test the effect of BGH on PDGF-BB-induced pro-
liferation of VSMCs, a 2,3-bis [2-methyloxy-4-nitro-5-
sulfophenyl]-2H-tetrazolium-5-carboxanilide (XTT) assay
was employed using EZ-Cytox Cell Viability Assay Kit.
The data demonstrated that BGH did not induce altered
cell viability and morphology at defined concentrations up
to 500 μg/mL compared with the untreated group (n = 3,
Fig. 1a). Treatment with BGH at varying concentrations
between 100–500 μg/mL inhibited PDGF-BB (10 ng/mL)-
induced proliferation of VSMCs in a dose-dependent
manner. The optimum effect was observed at 500 μg/mL
of BGH (n = 3, Fig. 1b).
BGH inhibits the migration of PDGF-BB-stimulated VSMCs
One of the causes of atherosclerosis is an abnormal migra-
tion of VSMCs in pathogenic condition that be induced
by PDGF and cytokines [7, 8]. Therefore, we determined
the measuring anti-migration effect of BGH by the scratch
wound healing and the boyden chamber assay with
PDGF-BB stimulation. First, in the case of scratch wound
healing assay, BGH significantly inhibited the PDGF-BB-
stimulated migration of VSMCs as shown by the reduc-
tion of the scratch area, in a dose-dependent manner
Fig. 1 The effect of Bo-Gan-Whan (BGH) on proliferation of PDGF-BB-stimulated VSMCs. a Cell Viability and b Proliferation Rates of VMSCs after
24 h treatment with BGH in a dose-dependent manner (10, 25, 50, 100, 250, and 500 μg/ mL). The graph shows the representative cell viability
from three independent experiments. Data are presented as mean ± standard error. Values with the same superscript letter are not significantly
different as analyzed by Tukey’s multiple range test (P < 0.05)
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(Fig. 2). The data confirms that the maximum inhibitory
effect of BGH treatment on PDGF-BB (10 ng/mL)-in-
duced cell migration was achieved at 500 μg/mL (n = 3,
Fig. 2). Next, the boyden chamber assay was performed to
assess whether BGH could inhibit cell migration of the
PDGF-BB-stimulated VSMCs within a short period.
VSMCs were treated with BGH (100, 250, and 500 μg/
mL) and PDGF-BB (10 ng/ mL) for 90 min. As shown in
Fig. 3, PDGF-BB (10 ng/ml) increased VSMC migration,
whereas BGH (100, 250, and 500 μg/ mL) significantly
inhibited PDGF-BB (10 ng/ml)-induced migration in a
dose-dependent manner (n = 6, Fig. 3).
BGH reduces the phosphorylation of p38 MAPK and
ERK1/2 in PDGF-stimulated VSMCs
Several studies have suggested that a key signal cascade
in PDGF-BB-induced VSMCSs is p38 MAPK and ERK1/
2 [10, 15]. Therefore, we tested whether BGH inhibits
the expression of phosphorylated p38 MAPK and ERK1/
2 in PDGF-BB-induced VSMCs using western blot ana-
lysis. PDGF-BB (10 ng/mL) increased the phosphoryl-
ation of ERK1/2 and p38 MAPK in VSMCs (n = 4, Fig. 4).
The phosphorylation of p38 MAPK was only reduced at a
concentration of 500 μg/mL BGH (Fig. 4b) whereas the
phosphorylation of ERK1/2 was inhibited by BGH treat-
ment (100, 250, and 500 μg/ mL) in a dose-dependent
manner (Fig. 4c).
BGH inhibits PDGF-BB-stimulated sprout outgrowth
To confirm the migration and proliferation of VSMCs
ex vivo, the aortic sprout outgrowth assay was performed.
PDGF-BB significantly increased the sprout outgrowth
from the aortic strips, whereas varying concentrations of
BGH (100, 250, and 500 μg/ mL) induced elimination of
the PDGF-BB-induced outgrowths in a dose-dependent
manner. This inhibitory response reached a maximum
level at 500 μg/mL of BGH (n = 3; Fig. 5).
The analysis of chromatogram and mass in the
composition of BGH
As shown in Fig. 6, to identify the composition of BGH,
we performed UPLC-based analysis. First, we detected a
major peak between Paeonia lactiflora root and BGH at
approximately 9.00 min employed UV-spectrum (Fig. 6a).
Next, we identified paeoniflorin from the mass of con-
stituents in its retention time, which was of 498.2003
molecular weights (Fig. 6b). Finally, we found BGH and
paeoniflorin according to MS spectra among Paeonia
lactiflora root (Fig. 6c).
Discussion
In this study, we demonstrated that Bo-Gan-Whan
(BGH), a Korean polyherbal medicine, has an inhibitory
effect on VSMC migration and proliferation in response
to PDGF-BB as revealed by the results obtained from the
scratch-wound healing and Boyden chamber assay and
sprout aortic ring assays, respectively. Moreover, it was
demonstrated through western blot analysis that the
modulation of MAPKs is the major signal that is activated
in the pathogenesis of VSMCs through activation of the
ERK1/2 and p38 MAPK pathways. These results were
confirmed from the ex vivo analysis of PDGF-BB-induced
VSMCs’ migration and proliferation. The data on ex vivo
analysis, through outgrowth of vessel sprouts from the
Fig. 2 Effects of Bo-Gan-Whan (BGH) on scratch wound-healing of PDGF-BB-stimulated VSMCs. VSMCs were treated with BGH (100–500 μg/mL)
and PDGF-BB (10 ng/mL) for 24 h. a Dotted white lines indicate the initial scratches. Magnification, 100×. Bar = 500 μm. b Migration rates of VMSCs
relative to the untreated group (%). Results are presented as mean ± standard error. Values with the same superscript letter are not significantly
different as analyzed by Tukey’s multiple range test (P < 0.05)
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aortic strips assay, show that BGH treatment can signifi-
cantly reduce VSMC migration and proliferation after
PDGF-BB stimulation.
Abnormal proliferation of VSMCs is a key to the vas-
cular pathological conditions such as atherosclerosis and
restenosis. Moreover, excessive migration of VSMCs in
vascular walls is one of the critical causes of vascular
neointima formation [4]. Therefore, suppression of VSMC
migration and proliferation may be one of the protective
strategies against restenosis or neointima formation in
atherosclerosis. Specifically, the present study shows that
BGH could be a potential medicine or supplement for
PDGF-BB-stimulated vascular remodeling since it can re-
markably inhibit VSMC proliferation and migration at the
highest dosage (500 μg/mL of BGH). Therefore, BGH
could be a potential therapeutic agent for preventing or
Fig. 3 Effects of Bo-Gan-Whan (BGH) on migration of PDGF-BB-stimulated VSMCs. VSMCs were treated with BGH (100, 250, and 500 μg/ mL) and
PDGF-BB (10 ng/mL) for 90 min. a Microphotographs of the migration patterns of VSMCs on membranes. The spots are Diff quick-stained cells.
Magnification = 200×. b Migration rates of BGH and PDGF-BB-treated VMSCs relative to the untreated group (%). Results are presented as mean ±
standard error. Values with the same superscript letter are not significantly different as analyzed by Tukey’s multiple range test (P < 0.05)
Fig. 4 Effect of Bo-Gan-Whan (BGH) on PDGF-BB induced phosphorylation of ERK1/2 and p38 MAPK in VSMCs. VSMCs were pretreated with or
without (100, 250, and 500 μg/ mL) BGH for 1 h and then stimulated with 10 ng/mL of PDGF-BB for 15 min. For statistical analysis, densitometry
of the band representing the phosphorylated form (p-ERK1/2 and p-p38) was normalized to the expression of their respective total forms
(T-ERK1/2 and T-p38). Western blot analysis of phosphorylated ERK1/2 (P-ERK1/2) and p38 MAPK (p-p38) (a) and their corresponding
relative intensities (b) and (c). Results are presented as the mean ± standard error of three independent experiments. Values with the same
superscript letters are not significantly different as analyzed by Tukey’s multiple range test (P < 0.05)
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treating pathological processes in restenosis and athero-
sclerosis. Moreover, the proliferative ability of various cells
including VSMCs was associated closely with MAPK
phosphorylation [15, 16]. Various studies have shown that
MAPKs are important signaling molecules in migration
and proliferation in response to PDGF-BB stimulation in
VSMCs [7, 8]. In this study, PDGF-BB-induced prolifera-
tion and outgrowth of vessel sprouts from the aortic strips
were suppressed by BGH treatment. These results imply
that BGH exerts an inhibitory effect on VSMC prolifera-
tion by inhibiting pathogenic vascular remodeling.
In normal vascular function, endothelial cells prevent
abnormal vascular remodeling such as hyperplasia of
smooth muscle cells. However, this protective role of
endothelial cells is no longer evident in patients follow-
ing exposure to stents, and they become more prone to
a number of risk factors that cause the narrowing of the
vascular lumen [17, 18]. Some review articles suggest
Fig. 5 Effect of Bo-Gan-Whan (BGH) on PDGF-BB-induced aortic sprout growth. The microphotographs of the aortic rings embedded in Matrigel,
treated with or without BGH (100, 250, and 500 μg/ mL) and PDGF-BB (10 ng/ml) are shown (a). The results were observed after four days of
incubation. b Also shown is the sprout outgrowth level in the untreated and BGH- and PDGF-BB-treated aortic rings, expressed as 100 % (n = 3). Results
are presented as the mean ± standard error of three independent experiments. Values with the same superscript letters are not significantly different
as analyzed by Tukey’s multiple range test (P < 0.05)
Fig. 6 UPLC-based Mass (MS) analysis of Bo-Gan-Whan (BGH). a The chromatograms of Paeonia lactiflora root (upper penal) and BGH (bottom
penal) during 12 min. The Arrows indicate the major peak of 9.01 and 9.00 min, respectively. b The mass profilie in the chromatogram at 9.0 min.
The arrow is indicated in 498.2003 M/Z. c MS spectra of Paeonia lactiflora root, BGH and Paeoniflorin. M/Z: mass to change ratio
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that administration of drugs and vitamins, either orally
or intravenously, is essential to prevent restenosis and
in-stent restenosis [19–21]. Although this therapeutic
strategy has been previously tested, it has not been
shown to be consistently helpful. Therefore, development
of functional foods has been gaining increasing attention.
For these reasons, the development of standardized and
effective alternative medicine is essential [11, 12].
The development of atherosclerosis is strongly linked
to lipid- metabolism [13, 17]. In addition to the anti-
atherosclerosis therapeutic activity of BGH, it also ex-
hibit hepato-protective effect by reducing liver damage
that is strongly associated with the development of
atherosclerosis. M. Ishigami et al. reported that apoE in-
hibits VSMC proliferation [22]. For this reason, we as-
sume that BGH can be among those hepato-protective
drug that can be prescribed in alternative in Korea. BGH
can be derived from six natural sources namely Osteri-
cum koreanum rhizome, Anglicae gigas root, Ledebour-
iella seseloides root, Paeonia lactiflora root, Rehmannia
glutinosa root, and Cnidium officinale. Makino. Bisabo-
langelone, one of the active components of Ostericum kor-
eanum, has been reported to have an anti-inflammatory
effect [23]. The crude extract of Anglicae gigans Radix
showed anti-tumor activity, anti-inflammation activity,
and anti-aggregation of platelets. Moreover, a component
of Anglicae gigans, decursin, has been reported to have
anti-tumor activity [24–27]. Bergapten, is one of the major
active components from Ledebouriella seseloides and has
been reported to have an anti-tumor effect [28, 29]. Paeo-
nia Radix is the root of a traditional oriental medicinal
herb named Paeonia lactiflora Pallas that has been used to
treat liver diseases and has therapeutic effect in rheuma-
toid arthritis [30]. Rehmannia glutinosa, on the other
hand, is widely used owing to its pharmacological effect
on the blood system, immune system, endocrine system,
cardiovascular system, and the nervous system [31]. Cnidii
Rhizoma, a dried root of Cnidium officinale Makino has
an anti-cancer effect [32, 33]. The extract form the rhi-
zome of Cnidium officinale has been reported to show
anti-inflammatory and anti-cancer activities [34]. Above
all, the Korean polyherbal medicine, BGH has been used
for liver protection. In present study, we identified paeoni-
florin as the major component of BGH as revealed by the
data using the UPLC. Some studies reported the paeoni-
florin have hepato-protective and anti-atherosclerosis ef-
fect [35, 36]. Therefore, we suggest that BGH may be used
as a functional food for prevention atherosclerosis and
restenosis.
Conclusion
The present study has demonstrated that BGH inhibits
cell migration, proliferation, and phosphorylation of
MAPKs in response to PDGF-BB stimulation in VSMCs.
BGH also attenuated the PDGF-BB-induced aortic sprout
outgrowth. From these results, the data suggests that
BGH could be a potential and a promising therapeutic
agent for the development of anti-restenosis or anti-
atherosclerotic drugs.
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